Macular degeneration, specifically age-related macular degeneration (AMD), is a leading cause of vision loss in older adults, affecting the central part of the retina known as the macula. This condition can result in blurred vision, difficulty recognizing faces, and a loss of the ability to see fine details, profoundly impacting daily life. AMD is generally categorized into two types: dry (atrophic) and wet (neovascular), each requiring different therapeutic approaches. While there is currently no cure for macular degeneration, advancements in medical treatments, including anti-VEGF injections, photodynamic therapy, and nutritional supplementation, have improved management strategies and outcomes. Understanding these treatment options is essential for individuals at risk or diagnosed with macular degeneration, empowering them to make informed decisions and maintain their vision for as long as possible.
|
|
|
|
